Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer Pharmaceutical Investing
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead and announces investigational clinical study results Life Science Investing News
Stagflation Looms: Why Economists Are Warning of a Rare and Painful Economic Storm Resource Investing News
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO Life Science Investing News
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump Life Science Investing News
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE for the Treatment of Glabellar Lines Pharmaceutical Investing
